General Archive

News releases

LifeArc plans two major funding calls to boost translational research in rare disease & lung health in cystic fibrosis

The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.
Read more
News releases

LifeArc joins the Campaign for Science and Engineering

Network of over 115 members works to put research at the heart of the UK’s future.
Read more
News releases

LifeArc Ventures launches new brand with dedicated website, LinkedIn and Twitter

Enabling LifeArc Ventures to speak directly to fellow investors, life science companies and entrepreneurial scientists.
Read more
News releases

From donkeys to diversity – Anji Miller reports from AUTM 2023

Takeaways from AUTM’s Annual Conference for the technology transfer sector
Read more
News releases

£3m fund to accelerate development of new CF therapies

Collaborative funding to drug discovery innovators to accelerate new treatments for people with cystic fibrosis.
Read more
News releases

LifeArc responds to the Government’s Spring Budget

LifeArc CEO Dr Melanie Lee responds to today’s Spring Budget.
Read more
News releases

The Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc

The Board at LifeArc announces today it is sponsoring five Daphne Jackson Fellowships.
Read more
News releases

LifeArc Ventures invests in Maxion Therapeutics

Investment in Maxion Therapeutics to drive antibody development for previously untreatable ion channel and GPCR-driven diseases
Read more
News releases

LifeArc Ventures – strong performance in 2022 & sustained investment in innovation

LifeArc Ventures, which is committed to investing in innovative early-stage life science companies, provides an update on its portfolio.
Read more
News releases

£1 million awarded to develop cutting-edge therapies for motor neuron disease

London, 24 January 2023: Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5 Doddie…
Read more
News releases

LifeArc portfolio company RQ Bio’s antibody enters clinical trials

The first of RQ Bio’s discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients has entered clinical trials.
Read more
News releases

Evolving our science to solve complex healthcare challenges

Dave Powell on why LifeArc is evolving the way we do our science – and the difference we hope it…
Read more